USB451438I5 - - Google Patents

Info

Publication number
USB451438I5
USB451438I5 US45143874A USB451438I5 US B451438 I5 USB451438 I5 US B451438I5 US 45143874 A US45143874 A US 45143874A US B451438 I5 USB451438 I5 US B451438I5
Authority
US
United States
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to US05/451,438 priority Critical patent/USRE29066E/en
Publication of USB451438I5 publication Critical patent/USB451438I5/en
Application granted granted Critical
Publication of USRE29066E publication Critical patent/USRE29066E/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
US05/451,438 1968-04-01 1974-03-15 Biodegradable radioactive particles Expired - Lifetime USRE29066E (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US05/451,438 USRE29066E (en) 1968-04-01 1974-03-15 Biodegradable radioactive particles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71796568A 1968-04-01 1968-04-01
US05/451,438 USRE29066E (en) 1968-04-01 1974-03-15 Biodegradable radioactive particles

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US71796568A Reissue 1968-04-01 1968-04-01

Publications (2)

Publication Number Publication Date
USB451438I5 true USB451438I5 (en) 1976-03-02
USRE29066E USRE29066E (en) 1976-12-07

Family

ID=24884246

Family Applications (2)

Application Number Title Priority Date Filing Date
US717965A Expired - Lifetime US3663685A (en) 1968-04-01 1968-04-01 Biodegradable radioactive particles
US05/451,438 Expired - Lifetime USRE29066E (en) 1968-04-01 1974-03-15 Biodegradable radioactive particles

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US717965A Expired - Lifetime US3663685A (en) 1968-04-01 1968-04-01 Biodegradable radioactive particles

Country Status (2)

Country Link
US (2) US3663685A (en)
CA (1) CA927281A (en)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937668A (en) * 1970-07-15 1976-02-10 Ilse Zolle Method for incorporating substances into protein microspheres
US4024233A (en) * 1972-06-05 1977-05-17 Medi-Physics, Inc. 99M-technetium labeled macroaggregated human serum albumin pharmaceutical
SE7412164L (en) * 1974-09-27 1976-03-29 Pharmacia Ab FUNDS FOR INTRAVASCULAR ADMINISTRATION
US3992513A (en) * 1975-01-07 1976-11-16 Atomic Energy Of Canada Limited Labelled phospholipid material colloidially dispersed and sized to localize at preselected organs
US4002730A (en) * 1975-01-13 1977-01-11 The Procter & Gamble Company Radionuclide carriers
US4053433A (en) * 1975-02-19 1977-10-11 Minnesota Mining And Manufacturing Company Method of tagging with color-coded microparticles
US4126669A (en) * 1975-06-02 1978-11-21 Pharmacia Aktiebolag Diagnostic agent
CA1077842A (en) * 1975-10-09 1980-05-20 Minnesota Mining And Manufacturing Company Albumin medicament carrier system
US4107283A (en) 1976-07-19 1978-08-15 New England Nuclear Corporation Tracer for circulation determinations
US4284472A (en) 1978-10-16 1981-08-18 General Electric Company Method for enhanced control of radioiodine in the production of fission product molybdenum 99
US4310506A (en) * 1979-02-22 1982-01-12 California Institute Of Technology Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species
US4431766A (en) * 1979-11-05 1984-02-14 Stauffer Chemical Company Coded polymeric material and method
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
US4323055A (en) * 1980-04-08 1982-04-06 Minnesota Mining And Manufacturing Company Radioactive iodine seed
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4569836A (en) * 1981-08-27 1986-02-11 Gordon Robert T Cancer treatment by intracellular hyperthermia
CH652599A5 (en) 1981-08-28 1985-11-29 Solco Basel Ag Method for producing colloidal physiological degradable, human serum albumin containing products and their use.
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
US4783484A (en) * 1984-10-05 1988-11-08 University Of Rochester Particulate composition and use thereof as antimicrobial agent
US4754745A (en) * 1984-11-21 1988-07-05 Horowitz Bruce S Conformable sheet material for use in brachytherapy
US4697575A (en) * 1984-11-21 1987-10-06 Henry Ford Hospital Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member
US4763642A (en) * 1986-04-07 1988-08-16 Horowitz Bruce S Intracavitational brachytherapy
US5069936A (en) * 1987-06-25 1991-12-03 Yen Richard C K Manufacturing protein microspheres
US5030441A (en) * 1989-05-30 1991-07-09 The United State Of America As Represented By The United States Department Of Energy Method of making colloid labeled with radionuclide
US5085848A (en) * 1989-05-30 1992-02-04 The United States Of America As Represented By The United States Department Of Energy Method of treating inflammatory diseases using a radiolabeled ferric hydroxide calloid
US4970062A (en) * 1989-05-30 1990-11-13 The United States Of America As Represented By The United States Department Of Energy Colloid labelled with radionuclide and method
US5320824A (en) * 1989-10-12 1994-06-14 Mallinckrodt Medical, Inc. Radionuclide labelled particles useful for radiation synovectomy
SE465950B (en) * 1989-10-23 1991-11-25 Medinvent Sa Combination of an aggregate particle size, crystalline or freeze-dried drug with a pseudoplastic gel for preparation of an injectable preparation as well as a process for its preparation
DE69129753T2 (en) * 1990-12-21 1998-10-22 Mallinckrodt Medical Inc RADIONUCLEOTIDE MARKED PARTICLES USEFUL FOR RADIATION SYNOVECTOMY
US6391343B1 (en) 1991-01-15 2002-05-21 Hemosphere, Inc. Fibrinogen-coated particles for therapeutic use
US5137709A (en) * 1991-02-15 1992-08-11 The Dow Chemical Company Layered mixed metal hydroxides for the stabilization of radioactive colloids
US5133956A (en) * 1991-05-30 1992-07-28 The Dow Chemical Company Radiolabeled metal-binding protein for the treatment of arthritis
WO1994010980A1 (en) 1992-11-16 1994-05-26 Corporation Of Mercer University Compositions using microencapsulated neutralizing antibodies
US7425543B2 (en) * 1992-11-16 2008-09-16 The Corporation Of Mercer University Microencapsulated materials and method of making same
CA2294494A1 (en) 1997-06-05 1998-12-10 Richard C. K. Yen Fibrinogen-coated microspheres
US5993374A (en) * 1997-06-17 1999-11-30 Radiance Medical Systems, Inc. Microcapsules for site-specific delivery
US5997463A (en) * 1998-03-26 1999-12-07 North American Scientific Laser welded brachytherapy source and method of making the same
AU1064800A (en) * 1998-11-12 2000-06-05 Nycomed Amersham Plc Products and methods
WO2000029501A1 (en) * 1998-11-18 2000-05-25 Emory University Radioactive coating solutions, methods, and substrates
EP2011008B1 (en) * 2006-03-13 2020-11-18 SMI Holding, Inc. Three-dimensional authentication of microparticle mark
US11524058B2 (en) 2008-09-29 2022-12-13 The Corporation Of Mercer University Oral dissolving films containing microencapsulated vaccines and methods of making same
US10463608B2 (en) 2008-09-29 2019-11-05 The Corporation Of Mercer University Microneedle-based transdermal delivery system and method of making same
EP2349219A4 (en) * 2008-09-29 2013-05-01 Univ Mercer Nanospheres encapsulating bioactive material and method for formulation of nanospheres
US10004790B2 (en) 2008-09-29 2018-06-26 The Corporation Of Mercer University Nanospheres encapsulating bioactive material and method for formulation of nanospheres
US9522964B2 (en) 2012-04-03 2016-12-20 Development, Inc. Micronized starch and methods for manufacturing same
US11628208B2 (en) 2015-10-05 2023-04-18 The Corporation Of Mercer University System and method for microneedle delivery of microencapsulated vaccine and bioactive proteins
WO2017062463A1 (en) 2015-10-05 2017-04-13 The Corporation Of Mercer University Nanospheres encapsulating bioactive material and method for formulation of nanospheres

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127313A (en) * 1964-03-31 Method of making a radioactive
US3061510A (en) * 1958-08-01 1962-10-30 Olin Mathieson Radioactive iodinated (i131) fatty material admixed with wax-like material in capsule
US3137631A (en) * 1959-12-01 1964-06-16 Faberge Inc Encapsulation in natural products
BE602237A (en) * 1960-04-07
US3121041A (en) * 1960-07-20 1964-02-11 Olin Mathieson Capsule containing a pharmaceutically useful radioactive material
US3329817A (en) * 1964-03-13 1967-07-04 Minnesota Mining & Mfg Radiation source
US3334050A (en) * 1964-08-24 1967-08-01 Minnesota Mining & Mfg Organic carbonaceous matrix with radioisotope dispersed therein
US3351049A (en) * 1965-04-12 1967-11-07 Hazleton Nuclear Science Corp Therapeutic metal seed containing within a radioactive isotope disposed on a carrier and method of manufacture
US3674900A (en) * 1967-01-03 1972-07-04 Lloyd M Thompson Radioactive macroaggregates of serum albumin
US3499962A (en) * 1967-08-24 1970-03-10 Nat Starch Chem Corp Encapsulation of water insoluble materials

Also Published As

Publication number Publication date
US3663685A (en) 1972-05-16
CA927281A (en) 1973-05-29
USRE29066E (en) 1976-12-07

Similar Documents

Publication Publication Date Title
USB451438I5 (en)
AU2374870A (en)
AU5184069A (en)
DE1916704C3 (en)
AU6171569A (en)
AU416157B2 (en)
AU2581067A (en)
AU2952567A (en)
AU4811568A (en)
AU421558B1 (en)
AU2580267A (en)
AU3224368A (en)
AU3789668A (en)
BE726920A (en)
BE728392A (en)
AU4464266A (en)
AU4503667A (en)
BE708888A (en)
BE642636A (en)
BE581157A (en)
BE728319A (en)
BE709301A (en)
AU3083868A (en)
BE709446A (en)
BE709479A (en)